Deloitte June 18, 2020
Even before the COVID-19 pandemic, 88 percent of health care providers had already invested in remote patient monitoring (RPM) or said they planned to do so in the future.1 In addition, a recent study conducted by the Deloitte Center for Health Solutions and the American Telemedicine Association found that 88 percent of health care executives predicted wearable devices would soon be integrated with care delivery—a clear derivative of consumer expectations for a tailored, hyper-personalized virtual health experience.
The reduced use of health care during the pandemic could drive greater adoption of RPM. For example, chronically ill patients who put off routine care during the pandemic could see their conditions worsen. RPM can be used to monitor and manage many chronic...